NCT03447145View on ClinicalTrials.gov

A New Drug Used for Advanced Cancer

PHASE1UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 26, 2017

Primary Completion Date

December 26, 2018

Study Completion Date

December 26, 2018

Conditions
Cancer
Interventions
DRUG

TQ-B3203

dose escalation, 2/4/6/10/14/18mg/m2

Trial Locations (1)

100021

RECRUITING

Beijing Cancer Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY